Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Tph cells are linked to the severity of systemic lupus erythematosus.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Certain skin symptoms can help detect and manage systemic lupus.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Hair chemicals don't cause SLE but may increase skin issues in those with SLE.

Fever and rash can be early signs of lupus.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

New treatments for lupus show promise, but more research is needed, especially for children.